Evidence map›Paper›PMID 42438762›Full record

ArticleIranian journal of pathology2026

Post-COVID-19 Rhinocerebral Mucormycosis, a Life-Threatening Event in the Background of an Immunosuppressive Condition: A Case Report.

Reihane Chegini, Ali Zare-Mirzaei, Mohammad Eslami

Abstract readCase Reports
In one paragraph

Article in Iranian journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Reihane CheginiDepartment of Pathology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ali Zare-MirzaeiDepartment of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mohammad EslamiDepartment of Pathology, Emam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Objective: In patients with COVID-19, immunocompromised conditions or immunosuppressive medications, such as corticosteroids, may predispose them to invasive fungal infections affecting the sinuses and brain. We describe a case of COVID-19 infection complicated by rhinocerebral mucormycosis, diagnosed through cerebrospinal fluid (CSF) analysis. Case Report: A 32-year-old woman with a history of COVID-19 1 month prior, treated with high-dose corticosteroids, presented with rapidly progressive neurological symptoms, including lower extremity paralysis. Imaging revealed an intracranial hemorrhage and a mass-like lesion. Conclusion: Cytological CSF analysis showed acute inflammation and fungal elements consistent with mucormycosis. Despite antifungal treatment, the patient's condition deteriorated; she developed a thromboembolism and ultimately died.

Indexed as

case reportCOVID-19immunosuppressionmucormycosisrhinocerebralSARS-CoV-2

Identifiers

PMID42438762
PMCPMC13356597

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.